Stay ahead with real-time news from 5,000+ trusted sources across global markets
Latest news from trusted sources across global markets
Get 10% back at IKEA, up to $27 max cash back…
Onto Innovation (ONTO) reports Q2 earnings Aug 6 after close.
Ocular Therapeutix eyes a 2027 AXPAXLI launch for wet AMD/retinal disease with strong Phase 3 data, an FDA-aligned NDA in Q4 2026. Click here to read more.